Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,880 | 2,980 | 06.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE ABOLISHMENT OF THE SUPERVISORY COMMITTEE | 1 | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): ELECTION OF NEW SESSION OF THE BOARD AND RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2025 FIRST H SHAREHOLDERS' CLASS MEETING TO BE HELD ON TUESDAY, 10 JUNE 2025 | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 10 JUNE 2025 | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): NOTICE OF 2025 FIRST H SHAREHOLDERS' CLASS MEETING | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): NOTICE OF 2024 ANNUAL GENERAL MEETING | 1 | HKEx | ||
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
09.05. | HAOHAI BIOTEC (06826): CIRCULAR OF 2024 ANNUAL GENERAL MEETING | - | HKEx | ||
07.05. | HAOHAI BIOTEC (06826): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. ANNOUNCEMENT ON THE RECEIPT OF NOTICE OF CASE ... | - | HKEx | ||
06.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
28.04. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): 2025 FIRST QUARTERLY REPORT | 1 | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): ARTICLES OF ASSOCIATION | 1 | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): AMENDMENTS TO THE ARTICLES OF ASSOCIATION | 1 | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024 | - | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): ANNUAL REPORT 2024 | - | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ... | 1 | HKEx | ||
25.04. | HAOHAI BIOTEC (06826): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ... | - | HKEx | ||
16.04. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
VALNEVA | 2,732 | -0,15 % | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy | Original-Research: Valneva SE - von First Berlin Equity Research GmbH 03.06.2025 / 14:27 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den... ► Artikel lesen | |
AMGEN | 254,90 | +0,08 % | Amgen Says Imdelltra Cut Risk Of Death By 40% In Small Cell Lung Cancer Patients | THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) Monday announced positive interim results from the Phase 3 DeLLphi-304 study showing Imdelltra reduced the risk of death by 40% and significantly... ► Artikel lesen | |
STRYKER | 337,40 | +0,12 % | Former Intuitive, Stryker VP joins Think Surgical as EVP to advance surgical robot tech | ||
REGENERON PHARMACEUTICALS | 434,60 | +0,44 % | Regeneron-Aktie crasht nach COPD-Daten - Verona Pharma schießt auf Allzeithoch | Bittere Pille für Regeneron Pharmaceuticals. Das Unternehmen und der Entwicklungspartner Sanofi haben in der vergangenen Handelswoche mit frischen Spätphasen-Studiendaten zum COPD-Hoffnungsträger Itepekimab... ► Artikel lesen | |
EXACT SCIENCES | 48,040 | -0,25 % | Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? | ||
CSL | 136,82 | -1,03 % | CSL LIMITED: Notification of cessation of securities - CSL | ||
CANSINO BIOLOGICS | 3,852 | -0,72 % | CANSINOBIO (06185): POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING | ||
BEONE MEDICINES LTD ADR | 226,00 | +0,89 % | BeOne Medicines Ltd.: BeOne Medicines präsentiert vielversprechende klinische Daten für zwei neuartige Brustkrebstherapien auf der ASCO 2025 | Vorläufige Ergebnisse unterstreichen die Antitumoraktivität und das günstige Sicherheitsprofil sowohl des B7-H4-gerichteten ADC als auch des CDK2-Inhibitors Die Daten unterstreichen die Stärke... ► Artikel lesen | |
BIOMERIEUX | 121,60 | -0,33 % | BIOMERIEUX: bioMérieux launches cutting-edge equine infectious respiratory disease testing | ||
SINO BIOPHARM | 0,485 | -2,94 % | Aktie von Sino Biopharmaceutical: Kurs mit wenig Bewegung (0,485 €) | Am Aktienmarkt ist die Sino Biopharmaceutical-Aktie zur Stunde unauffällig. Die Aktie notiert derzeit bei 0,485 Euro. Kaum auffällig ist gegenwärtig an der Börse der Kurs von Sino Biopharmaceutical.... ► Artikel lesen | |
ZAI LAB LTD ADR | 33,200 | -0,60 % | Zai Lab Limited: Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to show a clinically meaningful and statistically significant improvement in overall survival (OS) for... ► Artikel lesen | |
CSTONE PHARMACEUTICALS | 0,420 | -2,33 % | CSTONE PHARMA-B (02616): PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR AND ... | ||
CASI PHARMACEUTICALS | 1,820 | 0,00 % | CASI Pharmaceuticals Provides Business and Clinical Update | BEIJING, CHINA / ACCESS Newswire / May 19, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
3SBIO | 2,260 | +0,89 % | Rekorddeal beflügelt Biotech: 3SBio-Aktie schießt hoch: Pfizer setzt Milliarden auf chinesische Krebsforschung | © Foto: Foto: Nicolas Maeterlinck/ - BELGA/dpaPfizer geht mit einem Milliardeninvestment neue Wege in der Krebsforschung und stärkt den globalen Trend zur Lizenzierung chinesischer Biotech-Innovationen.Der... ► Artikel lesen | |
GENSCRIPT BIOTECH | 1,502 | +1,45 % | GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCED NEW 5-YEAR SURVIVAL DATA FOR CARVYKTI IN CARTITUDE-1 STUDY FOR MULTIPLE MYELOMA ... |